Vote Scores
Filings read through

Rapt Therapeutics, Inc.: how funds voted at the meeting of 29 May 2025

Meeting
Season
year to 30 June 2025
Filers reporting
144
Ballot items
6

144 filers on Form N-PX reported votes at the Rapt Therapeutics, Inc. meeting of 29 May 2025. The records fall into 6 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Rapt Therapeutics, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    1 nominee. 10.3% of the reported votes are for. 49 filers withheld from or voted against at least one nominee.

    97 vote records from 57 filers. 48 of the 57 filers that marked the item voted against management.

    • Positions of 23 fund families
    • For 3
    • Abstain or withhold 20
    • Against management 20
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    200 vote records from 143 filers. 114 of the 138 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 30 fund families
    • For 2
    • Against 27
    • Split or no vote 1
    • Against management 27
  3. Item 3: Frequency of the say-on-pay vote

    One year: 126 filers. Three years: 5 filers. For: 4 filers. Abstain: 1 filer. Against: 1 filer. None: 1 filer.

    200 vote records from 142 filers. 6 of the 137 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 30 fund families
    • Split or no vote 30
    • Against management 2
  4. Item 4: Audit-related items (auditor ratification)

    97 vote records from 57 filers. 0 of the 57 filers that marked the item voted against management.

    • Positions of 23 fund families
    • For 23
  5. Item 5: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    103 vote records from 57 filers. 2 of the 57 filers that marked the item voted against management.

    • Positions of 23 fund families
    • For 22
    • Against 1
    • Against management 1
  6. Item 6: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    188 vote records from 57 filers. 5 of the 57 filers that marked the item voted against management.

    • Positions of 23 fund families
    • Against 1
    • Split or no vote 22
    • Against management 1

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Rapt Therapeutics, Inc., meeting of 29 May 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinAgainst, against managementSplitNo report
BlackRock and iSharesAgainst, against managementSplitFor
BNY MellonAgainst, against managementSplitNo report
Charles SchwabAgainst, against managementSplitFor
DimensionalAgainst, against managementSplit, against managementFor
DWSAgainst, against managementSplitFor
EquitableAgainst, against managementSplitFor
Federated HermesAgainst, against managementSplitFor
FidelityAgainst, against managementSplitFor
First TrustSplitSplitNo report
Global XAgainst, against managementSplitFor
Goldman SachsAgainst, against managementSplitFor
Guggenheim and RydexAgainst, against managementSplitFor
InvescoAgainst, against managementSplitFor
J.P. MorganAgainst, against managementSplitNo report
Jackson National fundsAgainst, against managementSplit, against managementFor
Lincoln FinancialForSplitFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementSplitFor
NationwideAgainst, against managementSplitFor
Northern Trust and FlexSharesAgainst, against managementSplitFor
Nuveen and TIAAAgainst, against managementSplitFor
Pacific Life fundsAgainst, against managementSplitFor
PGIM and PrudentialAgainst, against managementSplitNo report
PrincipalAgainst, against managementSplitNo report
ProShares and ProFundsAgainst, against managementSplitFor
Russell InvestmentsAgainst, against managementSplitNo report
SEIAgainst, against managementSplitFor
State Street and SPDRForSplitFor
T. Rowe PriceAgainst, against managementSplitFor
VanguardAgainst, against managementSplitFor

Questions

How many filers reported votes at the Rapt Therapeutics, Inc. meeting?
144 Form N-PX filers reported votes at the meeting of 29 May 2025. On say-on-pay, 114 of 138 filers that marked the item voted against management (82.6%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Rapt Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Rapt Therapeutics, Inc. with a meeting date within three days of 29 May 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .